These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 13866880)

  • 1. Tissue activator of the fibrinolytic system in placental tissue.
    BELLER FK; GOESSNER W; HERRSCHLEIN HJ
    Obstet Gynecol; 1962 Jul; 20():117-9. PubMed ID: 13866880
    [No Abstract]   [Full Text] [Related]  

  • 2. The nature of the fibrinolytic-enzyme defect in hyaline-membrane disease.
    LIEBERMAN J
    N Engl J Med; 1961 Aug; 265():363-9. PubMed ID: 13762004
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fibrinolytic and esterase properties of human placenta extracts].
    KOTSCHY M; GLOGOWSKA I; KOTSCHY A
    Postepy Hig Med Dosw; 1960; 14():249-52. PubMed ID: 14411316
    [No Abstract]   [Full Text] [Related]  

  • 4. The cytopathic effect of fibrinolytic agents and human placental fractions on HeLa cells.
    THORNES RD; MARTIN WT
    Ir J Med Sci; 1961 Nov; 431():487-94. PubMed ID: 13921045
    [No Abstract]   [Full Text] [Related]  

  • 5. The fibrinolytic enzyme system and placental fibrin deposition.
    LITTLE WA; PHILLIPS LL
    Am J Obstet Gynecol; 1962 Aug; 84():421-3. PubMed ID: 14465906
    [No Abstract]   [Full Text] [Related]  

  • 6. [FIBRINOLYTIC ACTIVITY AND PLACENTA].
    MARZETTI L
    Quad Clin Ostet Ginecol; 1963 Aug; 18():505-10. PubMed ID: 14087999
    [No Abstract]   [Full Text] [Related]  

  • 7. METHOD OF PRODUCING PLASMIN FROM PLACENTAL SERUM FOR THERAPEUTIC PURPOSES.
    NEDKOV P; BOZADZIEV L; KARADZOVA M; VELEV V
    C R Acad Bulg Sci; 1964; 17():403-5. PubMed ID: 14175244
    [No Abstract]   [Full Text] [Related]  

  • 8. An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture.
    Holmberg L; Lecander I; Persson B; Astedt B
    Biochim Biophys Acta; 1978 Nov; 544(1):128-37. PubMed ID: 152655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
    Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
    Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research on a new fibrinolytic agent extracted from human placenta (Thromboclase)].
    Ponari O; Dallavalle L; Dettori AG; Gallese R
    Therapie; 1968; 23(4):737-50. PubMed ID: 4245312
    [No Abstract]   [Full Text] [Related]  

  • 11. PROFIBRINOLYSIN ACTIVATOR IN THE RAT PLACENTA.
    PHILLIPS LL; MCKAY DG
    Am J Obstet Gynecol; 1963 Sep; 87():56-62. PubMed ID: 14056187
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of cytofibrinokinase and fibrinolysin in extracts of tissue from human myometrium, endometrium, decidua, and placenta.
    PHILLIPS LL; BUTLER BC; TAYLOR HC
    Am J Obstet Gynecol; 1956 Feb; 71(2):342-9. PubMed ID: 13283010
    [No Abstract]   [Full Text] [Related]  

  • 13. Different inhibition of one and two chain tissue plasminogen activator by a placental inhibitor studied with two tripeptide-p-nitroanilide substrates.
    Astedt B; Bladh B; Christensen U; Lecander I
    Scand J Clin Lab Invest; 1985 Sep; 45(5):429-35. PubMed ID: 2930896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A histochemical study of endometrial and aborted placental tissue. II.
    MOORE ES; FRAZIER HM
    J Natl Med Assoc; 1962 Jan; 54(1):31-5. PubMed ID: 14475642
    [No Abstract]   [Full Text] [Related]  

  • 15. [Electrophoretic and chromatographic analysis of placental tissue].
    GIANNI AM; MURARI G; MOGGIAN G
    Bull Sci Med (Bologna); 1960; 132():328-35. PubMed ID: 13827843
    [No Abstract]   [Full Text] [Related]  

  • 16. The neuropeptide, head activator, in human placenta and serum from pregnant women.
    Sakura H; Aoki S; Ozawa T; Hashimoto T; Sakura N
    Acta Endocrinol (Copenh); 1991 Nov; 125(5):454-8. PubMed ID: 1759535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fibrinolytic enzyme system in the newborn.
    Beller F; Douglas GW; Epstein MD
    Am J Obstet Gynecol; 1966 Dec; 96(7):977-84. PubMed ID: 4224630
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fibrinolysis in certain cases of premature detachment of the placenta].
    KAESER O
    Rev Hematol; 1952; 7(1):55-9. PubMed ID: 14949746
    [No Abstract]   [Full Text] [Related]  

  • 19. Placenta and myometrium--the two main sources of fibrinolytic components during pregnancy.
    Uszyński M; Maciejewski K; Uszyński W; Kuczyński J
    Gynecol Obstet Invest; 2001; 52(3):189-93. PubMed ID: 11598362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemostatic system parameters of placental extracts in normal pregnancy and severe preeclampsia].
    López-Ramírez Y; Carvajal Z; Arocha-Piñango CL
    Invest Clin; 2006 Sep; 47(3):233-40. PubMed ID: 17672283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.